论文部分内容阅读
Objective: To improve the curative effect, we designed an EGFR targeting nanoparticulate formulation of arsenic trioxide(ATO) encapsulated in hollow mesoporous silica (Ni,As@SiO2-ZEGFR: 1907) for liver cancer treatment.